Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Novavax (NVAX) Reports Q1 Loss, Beats Revenue Estimates
Novavax (NVAX) Reports Q1 Loss, Beats Revenue Estimates

Novavax (NVAX) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to earnings of $2.93 per share a year ago. These figures are

New York Times (NYT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
New York Times (NYT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended March 2026, New York Times Co. (NYT) reported revenue of $712.24 million, up 12% over the same period last year. EPS came in at $0.61, compared to $0.41 in the year-ago

Is It Worth Investing in Petrobras (PBR) Based on Wall Street's Bullish Views?
Is It Worth Investing in Petrobras (PBR) Based on Wall Street's Bullish Views?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

MPLX LP (MPLX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
MPLX LP (MPLX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

MPLX LP (MPLX) reported $3.04 billion in revenue for the quarter ended March 2026, representing a year-over-year decline of 2.8%. EPS of $0.90 for the same period compares to $1.10 a year ago.

The

BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Beats Revenue EstimatesPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Beats Revenue Estimates

BioCryst Pharmaceuticals (BCRX) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of $0.06. This compares to break-even earnings per share a year ago. These

Here's What Key Metrics Tell Us About IQVIA (IQV) Q1 Earnings
Here's What Key Metrics Tell Us About IQVIA (IQV) Q1 Earnings

For the quarter ended March 2026, IQVIA Holdings (IQV) reported revenue of $4.15 billion, up 8.4% over the same period last year. EPS came in at $2.90, compared to $2.70 in the year-ago quarter.

The

Solventum (SOLV) Recently Broke Out Above the 50-Day Moving Average
Solventum (SOLV) Recently Broke Out Above the 50-Day Moving Average

From a technical perspective, Solventum (SOLV) is looking like an interesting pick, as it just reached a key level of support. SOLV recently overtook the 50-day moving average, and this suggests a

Stanley Black & Decker (SWK) Just Reclaimed the 200-Day Moving Average
Stanley Black & Decker (SWK) Just Reclaimed the 200-Day Moving Average

Stanley Black & Decker (SWK) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, SWK broke through the 200-day moving average, which

Stock Market News for May 6, 2026Photo, wide shot, wide-angle lens,  Coal company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.midjourneyapi.xyz/temp/2a011bdc-adca-4de9-8457-d868b31178cf.png
Stock Market News for May 6, 2026

U.S. stocks ended higher on Tuesday, with the S&P 500 and the Nasdaq hitting new all-time highs, as oil prices slid and robust earnings from AI-related stocks lifted investors’ sentiment. All three

Best Value Stocks to Buy for May 6thPhoto, wide shot, wide-angle lens, soft focus,  Underwriting company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-N0Y6W7kvQQgUHnb7hSHO9TTV.png?st=2024-05-14T11%3A36%3A30Z&se=2024-05-14T13%3A36%3A30Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2024-05-13T19%3A10%3A46Z&ske=2024-05-14T19%3A10%3A46Z&sks=b&skv=2021-08-06&sig=1qvKLOloU0OWrpqzcuH7YcgBv7QI0hAOq2gAtJGiGqs%3D
Best Value Stocks to Buy for May 6th

Here are three stocks with buy rank and strong value characteristics for investors to consider today, May 6th:  

Slide Insurance Holdings, Inc. SLDE: This company, which engages in underwriting

MTCH Q1 Earnings & Revenues Beat Estimates, Revenues Nearly Flat Y/Y
MTCH Q1 Earnings & Revenues Beat Estimates, Revenues Nearly Flat Y/Y

Match Group MTCH reported first-quarter 2026 earnings of 95 cents per share, which surpassed the Zacks Consensus Estimate by 3.26%. The bottom line grew 41.8% from the year-ago quarter’s reported

Best Income Stocks to Buy for May 6thPhoto, wide shot, wide-angle lens,  Coal mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/25526de2-54da-40ae-ba56-1e25dead3e81.png
Best Income Stocks to Buy for May 6th

Here are two stocks with buy rank and strong income characteristics for investors to consider today, May 6th:

EOG Resources EOG: This company, which is primarily engaged in the exploration and

Unlocking Q1 Potential of Somnigroup International (SGI): Exploring Wall Street Estimates for Key Metrics
Unlocking Q1 Potential of Somnigroup International (SGI): Exploring Wall Street Estimates for Key Metrics

In its upcoming report, Somnigroup International (SGI) is predicted by Wall Street analysts to post quarterly earnings of $0.57 per share, reflecting an increase of 16.3% compared to the same

What Analyst Projections for Key Metrics Reveal About News Corp. (NWSA) Q3 Earnings
What Analyst Projections for Key Metrics Reveal About News Corp. (NWSA) Q3 Earnings

Wall Street analysts forecast that News Corp. (NWSA) will report quarterly earnings of $0.16 per share in its upcoming release, pointing to a year-over-year decline of 5.9%. It is anticipated that

What Analyst Projections for Key Metrics Reveal About JFrog (FROG) Q1 Earnings
What Analyst Projections for Key Metrics Reveal About JFrog (FROG) Q1 Earnings

In its upcoming report, JFrog Ltd. (FROG) is predicted by Wall Street analysts to post quarterly earnings of $0.22 per share, reflecting an increase of 10% compared to the same period last year

Stay Ahead of the Game With Lincoln National (LNC) Q1 Earnings: Wall Street's Insights on Key Metrics
Stay Ahead of the Game With Lincoln National (LNC) Q1 Earnings: Wall Street's Insights on Key Metrics

Wall Street analysts expect Lincoln National (LNC) to post quarterly earnings of $1.63 per share in its upcoming report, which indicates a year-over-year increase of 1.9%. Revenues are expected to

Gear Up for Consolidated Water (CWCO) Q1 Earnings: Wall Street Estimates for Key Metrics
Gear Up for Consolidated Water (CWCO) Q1 Earnings: Wall Street Estimates for Key Metrics

In its upcoming report, Consolidated Water (CWCO) is predicted by Wall Street analysts to post quarterly earnings of $0.27 per share, reflecting a decline of 12.9% compared to the same period last

Exploring Analyst Estimates for Viatris (VTRS) Q1 Earnings, Beyond Revenue and EPS
Exploring Analyst Estimates for Viatris (VTRS) Q1 Earnings, Beyond Revenue and EPS

Wall Street analysts expect Viatris (VTRS) to post quarterly earnings of $0.52 per share in its upcoming report, which indicates a year-over-year increase of 4%. Revenues are expected to be $3.35

Exploring Analyst Estimates for Mosaic (MOS) Q1 Earnings, Beyond Revenue and EPS
Exploring Analyst Estimates for Mosaic (MOS) Q1 Earnings, Beyond Revenue and EPS

In its upcoming report, Mosaic (MOS) is predicted by Wall Street analysts to post quarterly earnings of $0.20 per share, reflecting a decline of 59.2% compared to the same period last year

Clearwater Analytics (CWAN) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Clearwater Analytics (CWAN) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Wall Street analysts expect Clearwater Analytics (CWAN) to post quarterly earnings of $0.16 per share in its upcoming report, which indicates a year-over-year increase of 23.1%. Revenues are

Ahead of HubSpot (HUBS) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Ahead of HubSpot (HUBS) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics

In its upcoming report, HubSpot (HUBS) is predicted by Wall Street analysts to post quarterly earnings of $2.47 per share, reflecting an increase of 38.8% compared to the same period last year

Globus Medical (GMED) Q1 Earnings Preview: What You Should Know Beyond the Headline EstimatesPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Globus Medical (GMED) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates

Wall Street analysts forecast that Globus Medical (GMED) will report quarterly earnings of $0.92 per share in its upcoming release, pointing to a year-over-year increase of 35.3%. It is

Gear Up for Plug Power (PLUG) Q1 Earnings: Wall Street Estimates for Key Metrics
Gear Up for Plug Power (PLUG) Q1 Earnings: Wall Street Estimates for Key Metrics

The upcoming report from Plug Power (PLUG) is expected to reveal quarterly loss of -$0.09 per share, indicating an increase of 57.1% compared to the year-ago period. Analysts forecast revenues of

What Analyst Projections for Key Metrics Reveal About Yelp (YELP) Q1 Earnings
What Analyst Projections for Key Metrics Reveal About Yelp (YELP) Q1 Earnings

Analysts on Wall Street project that Yelp (YELP) will announce quarterly earnings of $0.26 per share in its forthcoming report, representing a decline of 27.8% year over year. Revenues are

Halozyme Therapeutics (HALO) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Halozyme Therapeutics (HALO) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

The upcoming report from Halozyme Therapeutics (HALO) is expected to reveal quarterly earnings of $1.54 per share, indicating an increase of 38.7% compared to the year-ago period. Analysts forecast